Christina A. MacDougall brings an active background in the life sciences, chemistry, and healthcare to her intellectual property (IP) practice. She advises clients on patent counseling, global prosecution strategies (including portfolio management), opinions, and due diligence in the life sciences and related technology fields. This includes conducting invalidity and patentability searches and analyses for biochemical, molecular biological, and pharmaceutical products and processes. Clients rely on Christina to draft patent applications and analyze patent landscapes regarding competitive diligence and freedom to operate.
Before joining Morgan Lewis, Christina was an associate at another major law firm. There, she counseled clients that included startups, international biotechnology and drug discovery companies, and academic institutions, among others.
While working toward her Ph.D., Christina studied complex issues related to DNA damage recognition, and as an undergrad, she examined the cellular growth of prostate and other forms of cancer.
Boise State University, 2001, B.S.
Stanford University, 2007, Ph.D.
University of San Francisco School of Law, 2011, J.D.
U.S. Patent and Trademark Office
Next Generation Partner, Intellectual property: Patents: prosecution (including re-examination and post-grant proceedings), The Legal 500 US (2022)
Recommended, Intellectual property: Patents: licensing, The Legal 500 US (2020)
Member, Practice Group of the Year, Intellectual Property, Law360 (2019)
Member, Litigation Department of the Year–Intellectual Property, The American Lawyer (2019)
Member, Women's Intellectual Property Lawyers Association